Group Testing Performance Evaluation for SARS-COV-2 Massive Scale Screening and Testing
View ORCID ProfileOzkan Ufuk Nalbantoglu
doi: https://doi.org/10.1101/2020.05.02.20080390
Ozkan Ufuk Nalbantoglu
Department of Computer Engineering and Genome and Stem Cell Center, Erciyes University, Kayseri, Turkey

Data Availability
All code is available, please contract the author at ufuknalbantoglu{at}yahoo.com
Posted May 05, 2020.
Group Testing Performance Evaluation for SARS-COV-2 Massive Scale Screening and Testing
Ozkan Ufuk Nalbantoglu
medRxiv 2020.05.02.20080390; doi: https://doi.org/10.1101/2020.05.02.20080390
Subject Area
Subject Areas
- Addiction Medicine (270)
- Allergy and Immunology (552)
- Anesthesia (135)
- Cardiovascular Medicine (1757)
- Dermatology (173)
- Emergency Medicine (312)
- Epidemiology (10799)
- Gastroenterology (590)
- Genetic and Genomic Medicine (2949)
- Geriatric Medicine (287)
- Health Economics (534)
- Health Informatics (1928)
- Health Policy (836)
- Hematology (292)
- HIV/AIDS (630)
- Medical Education (299)
- Medical Ethics (86)
- Nephrology (324)
- Neurology (2799)
- Nursing (151)
- Nutrition (433)
- Oncology (1466)
- Ophthalmology (444)
- Orthopedics (172)
- Otolaryngology (257)
- Pain Medicine (190)
- Palliative Medicine (56)
- Pathology (381)
- Pediatrics (866)
- Primary Care Research (337)
- Public and Global Health (5366)
- Radiology and Imaging (1013)
- Respiratory Medicine (726)
- Rheumatology (330)
- Sports Medicine (279)
- Surgery (327)
- Toxicology (47)
- Transplantation (150)
- Urology (125)